170 related articles for article (PubMed ID: 23559304)
1. Dentine matrix protein 1 (DMP-1) is a marker of bone-forming tumours.
Kashima TG; Dongre A; Oppermann U; Athanasou NA
Virchows Arch; 2013 May; 462(5):583-91. PubMed ID: 23559304
[TBL] [Abstract][Full Text] [Related]
2. Dentine matrix protein 1 (DMP-1) is a marker of bone formation and mineralisation in soft tissue tumours.
Inagaki Y; Kashima TG; Hookway ES; Tanaka Y; Hassan AB; Oppermann U; Athanasou NA
Virchows Arch; 2015 Apr; 466(4):445-52. PubMed ID: 25630512
[TBL] [Abstract][Full Text] [Related]
3. Sclerostin expression in bone tumours and tumour-like lesions.
Inagaki Y; Hookway ES; Kashima TG; Munemoto M; Tanaka Y; Hassan AB; Oppermann U; Athanasou NA
Histopathology; 2016 Sep; 69(3):470-8. PubMed ID: 26896083
[TBL] [Abstract][Full Text] [Related]
4. Smooth muscle actin expression in primary bone tumours.
Hemingway F; Kashima TG; Mahendra G; Dhongre A; Hogendoorn PC; Mertens F; Athanasou NA
Virchows Arch; 2012 May; 460(5):525-34. PubMed ID: 22543453
[TBL] [Abstract][Full Text] [Related]
5. [Significance of SATB2 in the pathologic diagnosis of osteosarcoma].
Li M; Cai YP; Lu KY; Chen Y; Zhu X; Yin Y; Tang J
Zhonghua Bing Li Xue Za Zhi; 2016 Sep; 45(9):631-5. PubMed ID: 27646893
[TBL] [Abstract][Full Text] [Related]
6. Periostin expression in neoplastic and non-neoplastic diseases of bone and joint.
Brown JM; Mantoku A; Sabokbar A; Oppermann U; Hassan AB; Kudo A; Athanasou N
Clin Sarcoma Res; 2018; 8():18. PubMed ID: 30202513
[TBL] [Abstract][Full Text] [Related]
7. What's new in bone forming tumours of the skeleton?
Franceschini N; Lam SW; Cleton-Jansen AM; Bovée JVMG
Virchows Arch; 2020 Jan; 476(1):147-157. PubMed ID: 31741049
[TBL] [Abstract][Full Text] [Related]
8. Immunocytochemical identification of osteogenic bone tumors by osteonectin antibodies.
Jundt G; Schulz A; Berghäuser KH; Fisher LW; Gehron-Robey P; Termine JD
Virchows Arch A Pathol Anat Histopathol; 1989; 414(4):345-53. PubMed ID: 2496522
[TBL] [Abstract][Full Text] [Related]
9. SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours.
Conner JR; Hornick JL
Histopathology; 2013 Jul; 63(1):36-49. PubMed ID: 23701429
[TBL] [Abstract][Full Text] [Related]
10. Osteocytes serve as a progenitor cell of osteosarcoma.
Sottnik JL; Campbell B; Mehra R; Behbahani-Nejad O; Hall CL; Keller ET
J Cell Biochem; 2014 Aug; 115(8):1420-9. PubMed ID: 24700678
[TBL] [Abstract][Full Text] [Related]
11. Tumours of bone and their management.
Sweetnam R
Ann R Coll Surg Engl; 1974 Feb; 54(2):63-71. PubMed ID: 4594301
[TBL] [Abstract][Full Text] [Related]
12. MR imaging of primary bone tumors and tumor-like conditions in children.
Wootton-Gorges SL
Magn Reson Imaging Clin N Am; 2009 Aug; 17(3):469-87, vi. PubMed ID: 19524197
[TBL] [Abstract][Full Text] [Related]
13. Sclerostin expression in skeletal sarcomas.
Shen J; Meyers CA; Shrestha S; Singh A; LaChaud G; Nguyen V; Asatrian G; Federman N; Bernthal N; Eilber FC; Dry SM; Ting K; Soo C; James AW
Hum Pathol; 2016 Dec; 58():24-34. PubMed ID: 27498059
[TBL] [Abstract][Full Text] [Related]
14. Podoplanin expression in adamantinoma of long bones and osteofibrous dysplasia.
Kashima TG; Dongre A; Flanagan AM; Hogendoorn PC; Taylor R; Athanasou NA
Virchows Arch; 2011 Jul; 459(1):41-6. PubMed ID: 21499851
[TBL] [Abstract][Full Text] [Related]
15. Value of immunohistochemical detection of noncollagenous proteins of bone for the diagnosis of bone tumours.
Serra M; Scotlandi K; Sollazzo M; Sarti M; Maurici D; Benini S; Picci P; Bertoni F; Baldini N
Int J Oncol; 1996 Aug; 9(2):257-61. PubMed ID: 21541509
[TBL] [Abstract][Full Text] [Related]
16. [Tumors affecting the temporomandibular joint - a literature review].
Schlund M; Roland-Billecart T; Aubert S; Nicot R
Bull Cancer; 2020 Nov; 107(11):1186-1198. PubMed ID: 33059872
[TBL] [Abstract][Full Text] [Related]
17. Special AT-rich sequence-binding protein 2 (SATB2) expression is sensitive but may not be specific for osteosarcoma as compared with other high-grade primary bone sarcomas.
Davis JL; Horvai AE
Histopathology; 2016 Jul; 69(1):84-90. PubMed ID: 26644288
[TBL] [Abstract][Full Text] [Related]
18. YJ5 as an immunohistochemical marker of osteogenic lineage.
Chua K; Virshup DM; Odono EG; Chang KTE; Tan NJH; Hue SS; Sim AYL; Lee VKM
Pathology; 2021 Feb; 53(2):229-238. PubMed ID: 33187685
[TBL] [Abstract][Full Text] [Related]
19. Chondroblastoma of bone. A clinical, radiological, light and immunohistochemical study.
Edel G; Ueda Y; Nakanishi J; Brinker KH; Roessner A; Blasius S; Vestring T; Müller-Miny H; Erlemann R; Wuisman P
Virchows Arch A Pathol Anat Histopathol; 1992; 421(4):355-66. PubMed ID: 1384228
[TBL] [Abstract][Full Text] [Related]
20. The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas.
Machado I; Navarro S; Picci P; Llombart-Bosch A
Pathol Res Pract; 2016 Sep; 212(9):811-6. PubMed ID: 27465835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
